1079291-74-9

Upstream product

• 876131-19-0 5-[4-(4-benzyloxycarbonylaminobut-1-ynyl)phenyl]-2-(R)-tert-butoxycarbonylaminopent-4-ynoic acid methyl ester 

Downstream Products

• 876131-20-3 5-[4-(4-aminobutyl)phenyl]-2-(R)-tert-butoxycarbonylaminopentanoic acid methyl ester 

Relevant academic research and scientific papers

Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers

Prophylactic treatment methods are provided for protection of individuals and/or populations against infection from airborne pathogens. In particular, prophylactic treatment methods are provided comprising administering a sodium channel blocker or pharmaceutically acceptable salts thereof to one or more members of a population at risk of exposure to or already exposed to one or more airborne pathogens, either from natural sources or from intentional release of pathogens into the environment.

Soluble amide & ester pyrazinoylguanidine sodium channel blockers

The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.